title: Serotonin reuptake inhibitors are the treatment of choice in obsessive compulsive disorder.
authors.affiliation: Academic Department of Psychiatry, St Mary's Hospital Medical School, London, UK.
authors.forename: N A
authors.initials: NA
authors.lastname: Fineberg
authors.forename: T
authors.initials: T
authors.lastname: Bullock
authors.forename: D B
authors.initials: DB
authors.lastname: Montgomery
authors.forename: S A
authors.initials: SA
authors.lastname: Montgomery
mesh_terms: D015057:1-Naphthylamine / Q000031:analogs & derivatives / Q000627:therapeutic use; D001521:Behavior Therapy; D002997:Clomipramine / Q000627:therapeutic use; D003131:Combined Modality Therapy; D003866:Depressive Disorder / Q000188:drug therapy / Q000523:psychology; D016666:Fluvoxamine / Q000627:therapeutic use; D006801:Humans; D009771:Obsessive-Compulsive Disorder / Q000188:drug therapy* / Q000523:psychology; D012702:Serotonin Antagonists / Q000627:therapeutic use*; D020280:Sertraline
chemical_list: D012702:Serotonin Antagonists; D015057:1-Naphthylamine; D002997:Clomipramine; D016666:Fluvoxamine; D020280:Sertraline